Antibiotics modulate neoadjuvant therapy efficiency in patients with breast cancer: a pilot analysis
Abstract Mounting evidence suggests that microbiota dysbiosis caused by antibiotic administration is a risk factor for cancer, but few research reports focus on the relationships between antibiotics and chemotherapy efficiency. We evaluated the influence of antibiotic administration on neoadjuvant t...
Guardado en:
Autores principales: | Xi Zhang, Long Yu, Jiajie Shi, Sainan Li, Shiwei Yang, Wei Gao, Shan Yang, Meng Cheng, Haoqi Wang, Zhanjun Guo, Cuizhi Geng |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/df1ca7b9f0874707acaba8522009ef18 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Association between the nucleosome footprint of plasma DNA and neoadjuvant chemotherapy response for breast cancer
por: Xu Yang, et al.
Publicado: (2021) -
Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma
por: Willard Wong, et al.
Publicado: (2021) -
Neoadjuvant camrelizumab plus chemotherapy in treating locally advanced esophageal squamous cell carcinoma patients: a pilot study
por: Peng Yang, et al.
Publicado: (2021) -
Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer
por: Hyder T, et al.
Publicado: (2021) -
Current neoadjuvant treatment options for HER2 positive breast cancer
por: Abdel-Razeq H, et al.
Publicado: (2011)